Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Chirag Ved
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q1 (6 quarters; questions recorded in 4).
- Questions
- 5on tracked calls
- Challenge rate
- 0%none of 5 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 4with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 5 of 5 questions from 1 company
PATHUiPath Inc.5 questions · 4 reporting periods · 0 of 5 challenging
Calendar 2026 Q1
would you highlight health care and finance as the 2 verticals that are showing the strongest willingness to spend
Show response
Daniel confirmed healthcare (revenue cycle, denials, prior auth) and financial services, plus public sector, as the strongest verticals.
Calendar 2025 Q4
Which verticals do you see adopting these prebuilt agentic solutions the fastest?
Show response
Daniel said the verticalized approach is gaining traction, focused on healthcare (revenue cycle management) and financial services (financial crimes, KYC/AML), backed by a product/engineering reorg.
What are your thoughts on the balance between deterministic automation and agentic or LLM based automation.
Show response
Daniel said deterministic and agentic automation are complementary, addressing different process steps, with orchestration the key technology for reliable, governed enterprise AI.
Calendar 2025 Q2
Can you talk more about the GCP partnership and the partnership with Microsoft Copilot Studio
Show response
Daniel emphasized solutionizing verticals (citing the PEAK acquisition) and framed the Microsoft integration as a broad, open-platform play rather than giving specific economics.
Calendar 2024 Q4
You delivered a strong margin beat this past quarter. You called out the restructuring, but what drove the beat?
Show response
Ashim attributed the margin beat to execution discipline, efficiency and streamlining, and reiterated the Q4 guide rather than itemizing drivers.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| PATH UiPath Inc. | 5 | 0%none of 5 questions |
- PATHUiPath Inc. · 5 questions0%none of 5 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 1 | 0%none of 1 question | 1 |
| 2025 Q1 | No questions recorded | — | — |
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | No questions recorded | — | — |
| 2025 Q4 | 2 | 0%none of 2 questions | 1 |
| 2026 Q1 | 1 | 0%none of 1 question | 1 |
- 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q1No questions recorded
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q3No questions recorded
- 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Cloud & AI4
- Demand1
- Product Launch1
- Innovation & R&D1
- M&A1
- Margin1
- Cost Pressure1